Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Deconinck

Showing results (161-170 of 236) with videos related to

Pageof 24
Sort By:
Blood Advances|December 22, 2020
Optimizing selection of double cord blood units for transplantation of adult patients with malignant diseasesGiancarlo Fatobene, Fernanda Volt, Frederico Moreira, et al.
Blood|August 9, 2003
Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patientsKarim Belhadj, Felix Reyes, Jean-Pierre Farcet, et al.
Bone Marrow Transplantation|November 29, 2020
Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMTAnnalisa Paviglianiti, Myriam Labopin, Didier Blaise, et al.
British Journal of Haematology|March 31, 2022
An inherited gain-of-function risk allele in EPOR predisposes to familial JAK2<sup>V617F</sup> myeloproliferative neoplasmsGraciela Rabadan Moraes, Florence Pasquier, Christophe Marzac, et al.
American Journal of Hematology|November 21, 2018
Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remissionXavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Haematologica|May 12, 2018
Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationDalila Salvatore, Myriam Labopin, Annalisa Ruggeri, et al.
Blood Advances|December 6, 2024
Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasmSabine Khalife-Hachem, Arnaud Pages, Elie Akoury, et al.
Haematologica|May 28, 2016
Outcomes of unrelated cord blood transplantation in patients with multiple myeloma: a survey on behalf of Eurocord, the Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, and the Chronic Leukemia Working Party of the EBMTAnnalisa Paviglianiti, Erick Xavier, Annalisa Ruggeri, et al.
Ejhaem|July 18, 2022
BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR-T cell cytotoxicityMargaux Poussard, Laure Philippe, Maxime Fredon, et al.
Hemasphere|March 12, 2024
IDALLO study: A retrospective multicenter study of the SFGM-TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1-mutated AML after allogeneic hematopoietic cell transplantationAdrien Caillet, Marion Simonet-Boissard, Edouard Forcade, et al.
Pageof 24

Showing results (161-170 of 236) with videos related to

Sort By:
Pageof 24
Blood Advances|December 22, 2020
Optimizing selection of double cord blood units for transplantation of adult patients with malignant diseasesGiancarlo Fatobene, Fernanda Volt, Frederico Moreira, et al.
Blood|August 9, 2003
Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patientsKarim Belhadj, Felix Reyes, Jean-Pierre Farcet, et al.
Bone Marrow Transplantation|November 29, 2020
Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMTAnnalisa Paviglianiti, Myriam Labopin, Didier Blaise, et al.
British Journal of Haematology|March 31, 2022
An inherited gain-of-function risk allele in EPOR predisposes to familial JAK2<sup>V617F</sup> myeloproliferative neoplasmsGraciela Rabadan Moraes, Florence Pasquier, Christophe Marzac, et al.
American Journal of Hematology|November 21, 2018
Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remissionXavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Haematologica|May 12, 2018
Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationDalila Salvatore, Myriam Labopin, Annalisa Ruggeri, et al.
Blood Advances|December 6, 2024
Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasmSabine Khalife-Hachem, Arnaud Pages, Elie Akoury, et al.
Haematologica|May 28, 2016
Outcomes of unrelated cord blood transplantation in patients with multiple myeloma: a survey on behalf of Eurocord, the Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, and the Chronic Leukemia Working Party of the EBMTAnnalisa Paviglianiti, Erick Xavier, Annalisa Ruggeri, et al.
Ejhaem|July 18, 2022
BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR-T cell cytotoxicityMargaux Poussard, Laure Philippe, Maxime Fredon, et al.
Hemasphere|March 12, 2024
IDALLO study: A retrospective multicenter study of the SFGM-TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1-mutated AML after allogeneic hematopoietic cell transplantationAdrien Caillet, Marion Simonet-Boissard, Edouard Forcade, et al.
Pageof 24